3 Healthcare & Biotech Stocks up over 25% past 10 days
Powered by HealthTechMovers.com
Today, the screeners at HealthTechMovers.com picked up 3 Healthcare & Biotech Stocks up over 25% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com. Another great tool for charting is TradingView.com, so you might want to check that out too.
Summary: Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance.
Recent Price (approx 10:00am EST.): $$11
Previous Close: $10.92
Percentage Price Change Past 10 Days: +30%
TipRanks.com reports that Praxis Precision Medicines currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $56.50.
Click here to get the full story >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: AdaptHealth Corp. is a provider of home medical equipment primarily in the United States. It offers medical products for both rental and sale, with a focus on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers and hospital beds.
Recent Price (approx 10:00am EST.): $$17.41
Previous Close: $16.52
Percentage Price Change Past 10 Days: +30%
TipRanks.com reports that AdaptHealth currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $24.11.
Click here to get the full story >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors.
Recent Price (approx 10:00am EST.): $$10.14
Previous Close: $9.74
Percentage Price Change Past 10 Days: +25%
TipRanks.com reports that Caribou Biosciences currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $25.75.
Click here to get the full story >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
If you are looking for information on healthtech stocks, then please visit HealthTechMovers.com.
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com. The other great tool for charting is TradingView.com, so you might want to check that out too.
